|
US4880635B1
(en)
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
US4921757A
(en)
|
1985-04-26 |
1990-05-01 |
Massachusetts Institute Of Technology |
System for delayed and pulsed release of biologically active substances
|
|
US5109113A
(en)
|
1986-05-02 |
1992-04-28 |
Genentech, Inc. |
Membrane anchor fusion polypeptides
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
JPH0825869B2
(ja)
|
1987-02-09 |
1996-03-13 |
株式会社ビタミン研究所 |
抗腫瘍剤包埋リポソ−ム製剤
|
|
US4911928A
(en)
|
1987-03-13 |
1990-03-27 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
|
US4917951A
(en)
|
1987-07-28 |
1990-04-17 |
Micro-Pak, Inc. |
Lipid vesicles formed of surfactants and steroids
|
|
US5244797B1
(en)
|
1988-01-13 |
1998-08-25 |
Life Technologies Inc |
Cloned genes encoding reverse transcriptase lacking rnase h activity
|
|
US5223394A
(en)
|
1989-04-10 |
1993-06-29 |
Biogen, Inc. |
Recombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequence
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
DE69327229T2
(de)
|
1992-12-11 |
2000-03-30 |
The Dow Chemical Co., Midland |
Multivalente einkettige Antikörper
|
|
GB9304239D0
(en)
*
|
1993-03-01 |
1993-04-21 |
British Bio Technology |
Viral particles
|
|
BR9400600A
(pt)
|
1994-02-17 |
1995-10-24 |
Finep Financiadora De Estudos |
Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos
|
|
WO1995031183A1
(en)
|
1994-05-16 |
1995-11-23 |
Washington University |
Cell membrane fusion composition and method
|
|
EP2008664B1
(en)
|
1997-04-10 |
2012-08-29 |
University Of Southern California |
Modified proteins which bind extracellular matrix components
|
|
WO1998050538A1
(en)
*
|
1997-05-09 |
1998-11-12 |
Fred Hutchinson Cancer Research Center |
Mus dunni endogenous retroviral packaging cell lines
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
WO1999013905A1
(en)
|
1997-09-18 |
1999-03-25 |
The Trustees Of The University Of Pennsylvania |
Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery
|
|
US7994295B2
(en)
|
1997-12-22 |
2011-08-09 |
The University Of Tennessee Research Corporation |
Recombinant viruses comprising the membrane-proximal domain of VSV G protein
|
|
AU746454B2
(en)
|
1998-03-02 |
2002-05-02 |
Massachusetts Institute Of Technology |
Poly zinc finger proteins with improved linkers
|
|
FR2780069B1
(fr)
|
1998-06-23 |
2002-06-28 |
Inst Nat Sante Rech Med |
Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
|
|
DE69940521D1
(de)
|
1998-10-01 |
2009-04-16 |
Univ Southern California |
Retrovirales genübertragungssystem und entsprechendes verwendungverfahren
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US20030104526A1
(en)
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
GB9918680D0
(en)
|
1999-08-09 |
1999-10-13 |
Medical Res Council |
Polypeptide
|
|
WO2001027304A2
(en)
|
1999-10-12 |
2001-04-19 |
Institut Pasteur |
Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
|
|
CA2392490A1
(en)
|
1999-11-24 |
2001-05-31 |
Mcs Micro Carrier Systems Gmbh |
Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
|
|
AU2001262684A1
(en)
|
2000-06-01 |
2001-12-11 |
Dnavec Research Inc. |
Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity
|
|
DK1294892T3
(da)
|
2000-06-23 |
2008-01-28 |
Wyeth Corp |
Aggregering af vildtype- og kimære influenzaviruslignende partikler (VLP'er)
|
|
EP1201750A1
(en)
|
2000-10-26 |
2002-05-02 |
Genopoietic |
Synthetic viruses and uses thereof
|
|
US6395523B1
(en)
|
2001-06-01 |
2002-05-28 |
New England Biolabs, Inc. |
Engineering nicking endonucleases from type IIs restriction endonucleases
|
|
US7205056B2
(en)
|
2001-06-13 |
2007-04-17 |
Seiko Epson Corporation |
Ceramic film and method of manufacturing the same, ferroelectric capacitor, semiconductor device, and other element
|
|
US20040028687A1
(en)
|
2002-01-15 |
2004-02-12 |
Waelti Ernst Rudolf |
Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
|
|
AU2003251286B2
(en)
|
2002-01-23 |
2007-08-16 |
The University Of Utah Research Foundation |
Targeted chromosomal mutagenesis using zinc finger nucleases
|
|
US20030232410A1
(en)
|
2002-03-21 |
2003-12-18 |
Monika Liljedahl |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
|
JP2005521398A
(ja)
|
2002-03-27 |
2005-07-21 |
ベイラー カレッジ オブ メディスン |
癌治療用の強力な腫瘍溶解性単純ヘルペスウイルス
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
JP2006502748A
(ja)
|
2002-09-05 |
2006-01-26 |
カリフォルニア インスティテュート オブ テクノロジー |
遺伝子ターゲッティングを誘発するキメラヌクレアーゼの使用方法
|
|
PL377161A1
(pl)
|
2002-11-21 |
2006-01-23 |
Pevion Biotech Ltd. |
Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki
|
|
AU2004208031B2
(en)
|
2003-01-28 |
2009-10-08 |
Cellectis |
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
|
|
WO2004087748A1
(en)
|
2003-04-04 |
2004-10-14 |
Centre National De La Recherche Scientifique |
Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
|
|
US7011966B2
(en)
|
2003-04-16 |
2006-03-14 |
New England Biolabs, Inc. |
Method for cloning and expression of AcuI restriction endonuclease and AcuI methylase in E. coli
|
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7842673B2
(en)
|
2003-12-17 |
2010-11-30 |
The Trustees Of Columbia University In The City Of New York |
Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA
|
|
EP1773303A2
(en)
|
2004-05-25 |
2007-04-18 |
Chimeracore, Inc. |
Self-assembling nanoparticle drug delivery system
|
|
WO2006027202A1
(en)
|
2004-09-06 |
2006-03-16 |
Unite De Recherche En Biotherapie Et Oncologie (Rubio) |
Generation of multiparent cell hybrids
|
|
EP2292274A1
(en)
|
2004-09-16 |
2011-03-09 |
Sangamo BioSciences, Inc. |
Compositions and methods for protein production
|
|
US7998733B2
(en)
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
GB0426641D0
(en)
|
2004-12-03 |
2005-01-05 |
Bioactive Protein Delivery The |
Protein delivery system
|
|
US9034650B2
(en)
|
2005-02-02 |
2015-05-19 |
Intrexon Corporation |
Site-specific serine recombinases and methods of their use
|
|
WO2006089045A2
(en)
|
2005-02-18 |
2006-08-24 |
Monogram Biosciences, Inc. |
Methods and compositions for determining hypersusceptibility of hiv-1 to non-nucleoside reverse transcriptase inhibitors
|
|
AU2006224248B2
(en)
|
2005-03-15 |
2011-01-06 |
Cellectis |
I-Crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
|
CA2501301A1
(en)
|
2005-03-18 |
2006-09-18 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health |
Human endogenous foamy retrovirus and uses thereof
|
|
CA2611056C
(en)
|
2005-06-01 |
2016-06-28 |
California Institute Of Technology |
Method of targeted gene delivery using viral vectors
|
|
WO2007014275A2
(en)
|
2005-07-26 |
2007-02-01 |
Sangamo Biosciences, Inc. |
Targeted integration and expression of exogenous nucleic acid sequences
|
|
US9783791B2
(en)
|
2005-08-10 |
2017-10-10 |
Agilent Technologies, Inc. |
Mutant reverse transcriptase and methods of use
|
|
JP4938263B2
(ja)
|
2005-08-19 |
2012-05-23 |
独立行政法人農業生物資源研究所 |
一本鎖抗体によるサイトゾルタンパク質の機能阻害法およびその利用
|
|
EP2650366B1
(en)
|
2005-10-18 |
2017-03-22 |
Precision Biosciences |
Rationally designed meganucleases with altered sequence specificity and DNA-binding affinity
|
|
GB0526211D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Viral vectors
|
|
GB0526210D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Vectors
|
|
WO2007099387A1
(en)
|
2006-03-03 |
2007-09-07 |
Mymetics Corporation |
Virosome-like vesicles comprising gp41-derived antigens
|
|
EP2004677A2
(en)
|
2006-03-17 |
2008-12-24 |
Aarhus Universitet |
Chimeric viral envelopes
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
WO2008011120A2
(en)
|
2006-07-21 |
2008-01-24 |
The Regents Of The University Of California |
Human endogenous retrovirus polypeptide compositions and methods of use thereof
|
|
US20100120092A1
(en)
|
2006-08-30 |
2010-05-13 |
Hepgenics Pty Ltd. |
Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same
|
|
US20090143247A1
(en)
|
2007-03-15 |
2009-06-04 |
Pierre Emile Ulysse Martineau |
Methods for Producing Active scFv Antibodies and Libraries Therefor
|
|
CA2683063A1
(en)
|
2007-04-09 |
2008-10-16 |
Chimeros, Inc. |
Self-assembling nanoparticle drug delivery system
|
|
WO2008132722A1
(en)
|
2007-04-26 |
2008-11-06 |
Ramot At Tel-Aviv University Ltd. |
Pluripotent autologous stem cells from oral mucosa and methods of use
|
|
US8703469B2
(en)
|
2007-07-06 |
2014-04-22 |
Boyce Thompson Institute For Plant Research |
Baculoviruses with enhanced virion production and a method for the production of baculoviruses
|
|
CA2695433C
(en)
|
2007-08-03 |
2025-05-06 |
Institut Pasteur |
Antiviral gene transfer vectors and their medicinal applications
|
|
EP2036980A1
(de)
|
2007-09-14 |
2009-03-18 |
Gruber, Jens |
Herabregulation der Genexpression mittels Nukleinsäure-beladener virusähnlicher Partikel
|
|
US20090203140A1
(en)
|
2007-09-27 |
2009-08-13 |
Sangamo Biosciences, Inc. |
Genomic editing in zebrafish using zinc finger nucleases
|
|
SI2644192T1
(sl)
|
2007-09-28 |
2017-08-31 |
Pfizer Inc. |
Ciljanje rakavih celic z uporabo nanodelcev
|
|
WO2009134866A2
(en)
|
2008-04-29 |
2009-11-05 |
The Brigham And Women's Hospital, Inc. |
Cell membrane engineering
|
|
CA2725773C
(en)
|
2008-05-28 |
2017-12-05 |
Sangamo Biosciences, Inc. |
Compositions for linking dna-binding domains and cleavage domains
|
|
US9296790B2
(en)
|
2008-10-03 |
2016-03-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for protein delivery
|
|
DE102008050860A1
(de)
|
2008-10-08 |
2010-04-15 |
Dorothee Von Laer |
LCMV-GP-VSV-Pseudotypvektoren und tumorinfiltrierende Virenproduzentenzellen zur Therapie von Tumoren
|
|
WO2010063237A1
(zh)
|
2008-12-03 |
2010-06-10 |
中国科学院上海生命科学研究院 |
用于诊断，预防和治疗胰岛素抵抗的方法和试剂
|
|
JP5624994B2
(ja)
|
2009-01-09 |
2014-11-12 |
サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク |
新たなレセプター結合性リガンド、生物学的対象の細胞の検出におけるその使用
|
|
EP2398496B1
(en)
|
2009-02-20 |
2015-08-05 |
International AIDS Vaccine Initiative |
Vesicular stomatitis virus vectors encoding hiv env epitopes
|
|
CN102421791A
(zh)
|
2009-03-04 |
2012-04-18 |
得克萨斯系统大学评议会 |
稳定化逆转录酶融合蛋白
|
|
WO2010105251A2
(en)
|
2009-03-13 |
2010-09-16 |
Lentigen Corporation |
Non-integrating retroviral vector vaccines
|
|
EP2419144B1
(en)
|
2009-04-17 |
2019-08-07 |
Oxford University Innovation Limited |
Composition for delivery of genetic material
|
|
JP5667180B2
(ja)
|
2009-07-01 |
2015-02-12 |
イオン メディックス インコーポレイテッド |
哺乳類の有核細胞に由来するマイクロベシクル及びその用途
|
|
US8889394B2
(en)
|
2009-09-07 |
2014-11-18 |
Empire Technology Development Llc |
Multiple domain proteins
|
|
JP5878126B2
(ja)
|
2009-11-13 |
2016-03-08 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
工学操作された微小胞を用いての直接的なタンパク質の送達
|
|
EP2325322A1
(en)
|
2009-11-23 |
2011-05-25 |
4-Antibody AG |
Retroviral vector particles and methods for their generation and use
|
|
NO2510096T3
(enExample)
|
2009-12-10 |
2015-03-21 |
|
|
|
WO2011106376A2
(en)
|
2010-02-23 |
2011-09-01 |
The General Hospital Corporation |
Use of microvesicles in the treatment of medical conditions
|
|
US20130017210A1
(en)
|
2010-03-17 |
2013-01-17 |
Stc.Unm |
Display of antibody fragments on virus-like particles of rna bacteriophages
|
|
US20110311587A1
(en)
|
2010-06-04 |
2011-12-22 |
Pramila Walpita |
Fusogenic virus-like particles and uses thereof
|
|
WO2011159951A2
(en)
|
2010-06-17 |
2011-12-22 |
Sanford-Burnham Medical Research Institute |
Targeting tumor associated macrophages using bisphosphonate-loaded particles
|
|
US9458484B2
(en)
|
2010-10-22 |
2016-10-04 |
Bio-Rad Laboratories, Inc. |
Reverse transcriptase mixtures with improved storage stability
|
|
US9474911B2
(en)
|
2011-03-29 |
2016-10-25 |
Photokinetix Holdings Inc. |
Delivery of large molecular weight biologically active substances
|
|
US20140031259A1
(en)
*
|
2011-04-01 |
2014-01-30 |
Genentech, Inc. |
Biomarkers for predicting sensitivity to cancer treatments
|
|
US20140304847A1
(en)
|
2011-06-07 |
2014-10-09 |
Ralf Kühn |
Recombination efficiency by inhibition of nhej dna repair
|
|
US10081684B2
(en)
|
2011-06-28 |
2018-09-25 |
Whitehead Institute For Biomedical Research |
Using sortases to install click chemistry handles for protein ligation
|
|
WO2013025461A1
(en)
|
2011-08-12 |
2013-02-21 |
Virxsys Corporation |
Compositions and methods for inducing apoptosis
|
|
ES2618632T3
(es)
|
2011-09-28 |
2017-06-21 |
Zera Intein Protein Solutions, S.L. |
Inteínas divididas y usos de éstas
|
|
WO2013045639A1
(en)
|
2011-09-29 |
2013-04-04 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
LENTIVIRAL VECTORS PSEUDOTYPED WITH MUTANT BaEV GLYCOPROTEINS
|
|
EP2583974B1
(en)
|
2011-10-21 |
2017-04-26 |
Technische Universität Dresden |
Pseudotyping of foamy viruses
|
|
CN107875382B
(zh)
|
2011-11-11 |
2024-03-08 |
变异生物技术公司 |
用于治疗巨细胞病毒的组合物和方法
|
|
HK1200871A1
(en)
|
2011-11-16 |
2015-08-14 |
Sangamo Therapeutics, Inc. |
Modified dna-binding proteins and uses thereof
|
|
GB201121070D0
(en)
|
2011-12-07 |
2012-01-18 |
Isis Innovation |
composition for delivery of biotherapeutics
|
|
CN104080480A
(zh)
|
2012-01-01 |
2014-10-01 |
奇比艾企业有限公司 |
用于选择性递送治疗剂和诊断剂的endo180靶向微粒
|
|
WO2013119602A1
(en)
|
2012-02-06 |
2013-08-15 |
President And Fellows Of Harvard College |
Arrdc1-mediated microvesicles (armms) and uses thereof
|
|
EP2636746A1
(en)
|
2012-03-06 |
2013-09-11 |
Life Science Inkubator |
A novel drug delivery system based on JCV-VLP
|
|
US9610346B2
(en)
|
2012-03-23 |
2017-04-04 |
International Aids Vaccine Initiative |
Recombinant viral vectors
|
|
EP3971286A3
(en)
|
2012-03-26 |
2022-04-20 |
The Regents of the University of California |
Nipah virus envelope pseudotyped lentiviruses and methods of use
|
|
EP3663395B1
(en)
|
2012-03-26 |
2024-07-31 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services Office of Technology, Transfer, |
Delivery of packaged rna to mammalian cells
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
AU2013280693B2
(en)
|
2012-06-27 |
2018-01-04 |
The Trustees Of Princeton University |
Split inteins, conjugates and uses thereof
|
|
CA2877384C
(en)
|
2012-07-02 |
2023-05-09 |
Iprogen Biotech Inc. |
Intracellular protein delivery
|
|
US9181535B2
(en)
|
2012-09-24 |
2015-11-10 |
The Chinese University Of Hong Kong |
Transcription activator-like effector nucleases (TALENs)
|
|
AU2013326968B2
(en)
|
2012-10-03 |
2019-08-08 |
Agrivida, Inc. |
Multiprotein expression cassettes
|
|
JO3470B1
(ar)
|
2012-10-08 |
2020-07-05 |
Merck Sharp & Dohme |
مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
|
|
SG11201501623PA
(en)
|
2012-10-30 |
2015-05-28 |
Redvax Gmbh |
Recombinant particle based vaccines against human cytomegalovirus infection
|
|
WO2014071070A1
(en)
|
2012-11-01 |
2014-05-08 |
Pacific Biosciences Of California, Inc. |
Compositions and methods for selection of nucleic acids
|
|
CA2893926A1
(en)
|
2012-12-06 |
2014-06-12 |
Exxonmobil Research And Engineering Company |
Dgat genes comprising pleckstrin homology domains and use in recombinant microorganisms
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
EP2896697B1
(en)
|
2012-12-12 |
2015-09-02 |
The Broad Institute, Inc. |
Engineering of systems, methods and optimized guide compositions for sequence manipulation
|
|
EP2931898B1
(en)
*
|
2012-12-12 |
2016-03-09 |
The Broad Institute, Inc. |
Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
|
|
US9393257B2
(en)
|
2013-03-01 |
2016-07-19 |
Regents Of The University Of Minnesota |
TALEN-based gene correction
|
|
US9504747B2
(en)
|
2013-03-08 |
2016-11-29 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
EP3608308B1
(en)
|
2013-03-08 |
2021-07-21 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
SG11201508433TA
(en)
|
2013-04-12 |
2015-11-27 |
Andaloussi Samir El |
Therapeutic delivery vesicles
|
|
CN105377942B
(zh)
|
2013-05-14 |
2018-07-31 |
加州理工学院 |
通过跨越血脑屏障的纳米颗粒递送治疗剂和显像剂的方法
|
|
CN105283553B
(zh)
|
2013-06-11 |
2021-06-25 |
克隆技术实验室有限公司 |
蛋白质富集的微泡及其制备和使用方法
|
|
MX2015017312A
(es)
|
2013-06-17 |
2017-04-10 |
Broad Inst Inc |
Suministro y uso de composiciones, vectores y sistemas crispr-cas para la modificación dirigida y terapia hepáticas.
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US20160208221A1
(en)
|
2013-09-12 |
2016-07-21 |
Apse, Llc |
Compositions and methods using capsids resistant to hydrolases
|
|
US9829483B2
(en)
|
2013-09-26 |
2017-11-28 |
The General Hospital Corporation |
Methods of isolating extracellular vesicles
|
|
US10538570B2
(en)
|
2013-09-30 |
2020-01-21 |
Northwestern University |
Targeted and modular exosome loading system
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
CN111206032B
(zh)
|
2013-12-12 |
2024-07-19 |
布罗德研究所有限公司 |
用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用
|
|
PT3083556T
(pt)
|
2013-12-19 |
2020-03-05 |
Novartis Ag |
Lípidos e composições lipídicas para a entrega de agentes ativos
|
|
CA2935929C
(en)
|
2014-01-10 |
2022-02-22 |
Sirion Biotech Gmbh |
Pseudotyped lentiviral vectors
|
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
US20170173113A1
(en)
|
2014-03-13 |
2017-06-22 |
Research Institute At Nationwide Children's Hospital |
Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes
|
|
US20160051697A1
(en)
|
2014-04-07 |
2016-02-25 |
The Board Of Regents For Oklahoma State University |
Nanodelivery device for therapeutic loading of circulating erythrocytes
|
|
KR20170068410A
(ko)
|
2014-04-29 |
2017-06-19 |
내셔날 헬스 리서치 인스티튜트 |
엔테로바이러스 감염증에 대항하는 아데노바이러스 벡터-기반 백신
|
|
US20150344523A1
(en)
|
2014-05-05 |
2015-12-03 |
California Institute Of Technology |
Mutant akt-specific capture agents, compositions, and methods of using and making
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
WO2015191911A2
(en)
*
|
2014-06-12 |
2015-12-17 |
Clontech Laboratories, Inc. |
Protein enriched microvesicles and methods of making and using the same
|
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
US10583104B2
(en)
|
2014-08-06 |
2020-03-10 |
Indiana University Research And Technology Corporation |
Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
|
|
WO2016037985A1
(en)
|
2014-09-08 |
2016-03-17 |
Ruprecht-Karls-Universität Heidelberg |
Construct for the delivery of a molecule into the cytoplasm of a cell
|
|
US10010607B2
(en)
|
2014-09-16 |
2018-07-03 |
Institut Curie |
Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response
|
|
IL287561B2
(en)
|
2014-10-01 |
2024-03-01 |
Massachusetts Gen Hospital |
Methods for increasing efficiency of nuclease-induced homology-directed repair
|
|
DK3212778T3
(da)
|
2014-10-28 |
2019-11-04 |
Agrivida Inc |
Fremgangsmåder og sammensætninger til stabilisering af trans-splejsning af intein-modificerede proteaser
|
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
|
WO2016089433A1
(en)
|
2014-12-03 |
2016-06-09 |
Agilent Technologies, Inc. |
Guide rna with chemical modifications
|
|
IL301458A
(en)
|
2014-12-24 |
2023-05-01 |
Autolus Ltd |
A cell that simultaneously expresses a chimeric antigen receptor (CAR) of 19CD and 22CD
|
|
WO2016131009A1
(en)
|
2015-02-13 |
2016-08-18 |
University Of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
US10501733B2
(en)
|
2015-02-27 |
2019-12-10 |
University Of Washington |
Polypeptide assemblies and methods for the production thereof
|
|
US12060391B2
(en)
|
2015-03-16 |
2024-08-13 |
The Broad Institute, Inc. |
Constructs for continuous monitoring of live cells
|
|
WO2016149384A1
(en)
|
2015-03-18 |
2016-09-22 |
University Of Massachusetts |
Virus-like particle compositions and vaccines against epstein-barr virus infection and disease
|
|
US11124775B2
(en)
|
2015-05-15 |
2021-09-21 |
Flash Therapeutics |
Retroviral particle comprising at least two encapsidated nonviral RNAs
|
|
IL256175B2
(en)
|
2015-06-10 |
2024-10-01 |
Univ Texas |
Using exosomes to treat the disease
|
|
ES2886599T3
(es)
|
2015-06-17 |
2021-12-20 |
Poseida Therapeutics Inc |
Composiciones y métodos para dirigir proteínas a loci específicos en el genoma
|
|
US10624849B2
(en)
|
2015-09-28 |
2020-04-21 |
Northwestern University |
Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
|
|
WO2017059241A1
(en)
|
2015-10-02 |
2017-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lentiviral protein delivery system for rna-guided genome editing
|
|
EP3365437B1
(en)
|
2015-10-20 |
2025-06-04 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods and products for genetic engineering
|
|
WO2017068077A1
(en)
|
2015-10-20 |
2017-04-27 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and products for genetic engineering
|
|
SG10202104041PA
(en)
|
2015-10-23 |
2021-06-29 |
Harvard College |
Nucleobase editors and uses thereof
|
|
US20170112773A1
(en)
|
2015-10-23 |
2017-04-27 |
Board Of Regents, The University Of Texas System |
Plasma membrane vesicles comprising functional transmembrane proteins
|
|
CA3040071A1
(en)
*
|
2015-12-17 |
2017-06-22 |
The Penn State Research Foundation |
Paramyxovirus virus-like particles as protein delivery vehicles
|
|
CN109415728A
(zh)
|
2016-02-15 |
2019-03-01 |
天普大学-联邦高等教育系统 |
逆转录病毒核酸序列的切除
|
|
EP3265263B1
(de)
|
2016-02-23 |
2018-12-12 |
Fronius International GmbH |
Schweissvorrichtung mit einer laservorwärmeinrichtung für zusatzdraht
|
|
SG10202008883SA
(en)
|
2016-03-15 |
2020-10-29 |
Codiak Biosciences Inc |
Therapeutic membrane vesicles
|
|
US11597924B2
(en)
|
2016-03-25 |
2023-03-07 |
Editas Medicine, Inc. |
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
|
|
SI3436077T1
(sl)
|
2016-03-30 |
2025-07-31 |
Intellia Therapeutics, Inc. |
Formulacije lipidnih nanodelcev za komponente crispr/cas
|
|
AU2017253107B2
(en)
|
2016-04-19 |
2023-07-20 |
Massachusetts Institute Of Technology |
CPF1 complexes with reduced indel activity
|
|
EP3235828A1
(en)
|
2016-04-21 |
2017-10-25 |
Genethon |
Stable pseudotyped lentiviral particles and uses thereof
|
|
EP3235908A1
(en)
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
US10870865B2
(en)
|
2016-05-13 |
2020-12-22 |
Flash Therapeutics |
Particle for the encapsidation of a genome engineering system
|
|
CA3023788A1
(fr)
|
2016-05-13 |
2017-11-16 |
Flash Therapeutics |
Particule virale pour le transfert d'arns, notamment dans les cellules impliquees dans la reponse immune
|
|
GB201609216D0
(en)
|
2016-05-25 |
2016-07-06 |
Evox Therapeutics And Isis Innovation Ltd |
Exosomes comprising therapeutic polypeptides
|
|
GB201610041D0
(en)
|
2016-06-08 |
2016-07-20 |
Oxford Genetics Ltd |
Methods
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
US10337051B2
(en)
|
2016-06-16 |
2019-07-02 |
The Regents Of The University Of California |
Methods and compositions for detecting a target RNA
|
|
US11788083B2
(en)
|
2016-06-17 |
2023-10-17 |
The Broad Institute, Inc. |
Type VI CRISPR orthologs and systems
|
|
GB2552301A
(en)
|
2016-07-11 |
2018-01-24 |
Evox Therapeutics Ltd |
Metabolic drug loading of EVs
|
|
GB2552460A
(en)
|
2016-07-11 |
2018-01-31 |
Evox Therapeutics Ltd |
CPP-Mediated EV Loading
|
|
GB2552473A
(en)
*
|
2016-07-21 |
2018-01-31 |
Evox Therapeutics Ltd |
Surface decoration of extracellular vesicles
|
|
EP3275462A1
(en)
|
2016-07-27 |
2018-01-31 |
Fundació Privada Institut de Recerca de la SIDA-Caixa |
Virus-like particles with high-density coating for the production of neutralizing antibodies
|
|
KR20250103795A
(ko)
|
2016-08-03 |
2025-07-07 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
IL308824A
(en)
|
2016-08-17 |
2024-01-01 |
Factor Bioscience Inc |
Nucleic acid products and methods of administration thereof
|
|
WO2018035387A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2018035388A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
US9580698B1
(en)
|
2016-09-23 |
2017-02-28 |
New England Biolabs, Inc. |
Mutant reverse transcriptase
|
|
WO2018067546A1
(en)
|
2016-10-03 |
2018-04-12 |
President And Fellows Of Harvard College |
Delivery of therapeutic rnas via arrdc1-mediated microvesicles
|
|
US20180245065A1
(en)
|
2016-11-01 |
2018-08-30 |
Novartis Ag |
Methods and compositions for enhancing gene editing
|
|
JP7231226B2
(ja)
*
|
2016-11-07 |
2023-03-01 |
ユニバーシティ オブ マサチューセッツ |
顔面肩甲上腕型筋ジストロフィーのための治療標的
|
|
EP3540056A4
(en)
|
2016-11-10 |
2020-06-03 |
Kaneka Corporation |
METHOD FOR PRODUCING TRANSGENIC CELLS
|
|
US11192929B2
(en)
|
2016-12-08 |
2021-12-07 |
Regents Of The University Of Minnesota |
Site-specific DNA base editing using modified APOBEC enzymes
|
|
MY206324A
(en)
|
2016-12-08 |
2024-12-10 |
Intellia Therapeutics Inc |
Modified guide rnas
|
|
CN110072994A
(zh)
|
2016-12-23 |
2019-07-30 |
埃克波菲尔有限公司 |
用于纯化或分离微泡和外泌体的方法与组合物
|
|
GB201702863D0
(en)
|
2017-02-22 |
2017-04-05 |
Evox Therapeutics Ltd |
Improved loading of EVs with therapeutic proteins
|
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
US12350368B2
(en)
|
2017-04-14 |
2025-07-08 |
The Broad Institute, Inc. |
Delivery of large payloads
|
|
ES3052812T3
(en)
|
2017-05-08 |
2026-01-14 |
Flagship Pioneering Innovations V Inc |
Compositions for facilitating membrane fusion and uses thereof
|
|
US20210189432A1
(en)
|
2017-05-10 |
2021-06-24 |
University Of Utah Research Foundation |
Compositions and methods of use of arc capsids
|
|
AU2018273986A1
(en)
|
2017-05-25 |
2019-12-12 |
The General Hospital Corporation |
Bipartite base editor (BBE) architectures and type-II-C-Cas9 zinc finger editing
|
|
AU2018280116B2
(en)
|
2017-06-05 |
2025-03-27 |
Research Institute At Nationwide Children's Hospital |
Enhanced modified viral capsid proteins
|
|
IL271275B1
(en)
|
2017-06-13 |
2026-04-01 |
Flagship Pioneering Innovations V Inc |
Preparations containing croons and their uses
|
|
JP2020530438A
(ja)
|
2017-06-22 |
2020-10-22 |
アンスティテュ ギュスタフ ルッシーＩｎｓｔｉｔｕｔ Ｇｕｓｔａｖｅ Ｒｏｕｓｓｙ |
ヒト内在性レトロウイルスタンパク質
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
AU2018316803B2
(en)
|
2017-08-17 |
2021-07-15 |
Ilias Biologics Inc. |
Exosomes for target specific delivery and methods for preparing and delivering the same
|
|
WO2019043127A1
(en)
*
|
2017-09-01 |
2019-03-07 |
Inprother Aps |
VACCINE FOR USE IN PROPHYLAXIS AND / OR TREATMENT OF DISEASE
|
|
FI3688162T3
(fi)
|
2017-09-29 |
2024-05-15 |
Intellia Therapeutics Inc |
Formulaatioita
|
|
US11795443B2
(en)
|
2017-10-16 |
2023-10-24 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
IL273923B2
(en)
|
2017-10-20 |
2024-08-01 |
Genethon |
Using syncytin for drug targeting and gene delivery to lung tissue
|
|
US10882915B2
(en)
|
2017-10-24 |
2021-01-05 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of CD117+ cells
|
|
GB201717446D0
(en)
|
2017-10-24 |
2017-12-06 |
Evox Therapeutics Ltd |
Affinity purification of engineering extracellular vesicles
|
|
FR3072973B1
(fr)
|
2017-10-26 |
2022-02-11 |
Univ Pierre Et Marie Curie Paris 6 |
Particules pseudo-virales utiles pour traiter des dysfonctionnements immunitaires
|
|
US11970719B2
(en)
|
2017-11-01 |
2024-04-30 |
The Regents Of The University Of California |
Class 2 CRISPR/Cas compositions and methods of use
|
|
AU2018358051B2
(en)
|
2017-11-01 |
2025-01-09 |
The Regents Of The University Of California |
CasZ compositions and methods of use
|
|
US20210187018A1
(en)
|
2017-12-07 |
2021-06-24 |
Flagship Pioneering Innovations V, Inc. |
Cytobiologics and therapeutic uses thereof
|
|
US20210163933A1
(en)
|
2017-12-11 |
2021-06-03 |
University Of Massachusetts |
Arc protein extracellular vesicle nucleic acid delivery platform
|
|
US11660355B2
(en)
|
2017-12-20 |
2023-05-30 |
Cedars-Sinai Medical Center |
Engineered extracellular vesicles for enhanced tissue delivery
|
|
US20200392473A1
(en)
|
2017-12-22 |
2020-12-17 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
GB201802163D0
(en)
|
2018-02-09 |
2018-03-28 |
Evox Therapeutics Ltd |
Compositions for EV storage and formulation
|
|
SG11202007606QA
(en)
|
2018-02-17 |
2020-09-29 |
Flagship Pioneering Innovations V Inc |
Compositions and methods for membrane protein delivery
|
|
GB201804291D0
(en)
|
2018-03-16 |
2018-05-02 |
Evox Therapeutics Ltd |
Cell-mediated exosome delivery
|
|
CN112218621A
(zh)
|
2018-04-10 |
2021-01-12 |
西北大学 |
包含基于靶向亲和域的膜蛋白的胞外囊泡
|
|
US12398182B2
(en)
|
2018-05-01 |
2025-08-26 |
Wake Forest University Health Sciences |
Lentiviral-based vectors and related systems and methods for eukaryotic gene editing
|
|
KR20250133482A
(ko)
|
2018-05-11 |
2025-09-05 |
빔 테라퓨틱스, 인크. |
프로그래밍가능한 염기 편집기 시스템을 이용하여 단일 뉴클레오티드 다형성을 편집하는 방법
|
|
EP3790964A4
(en)
|
2018-05-11 |
2022-06-08 |
Beam Therapeutics, Inc. |
METHODS FOR REMOVAL OF PATHOGENIC MUTATIONS USING PROGRAMMABLE BASE EDITOR SYSTEMS
|
|
MX2020012295A
(es)
|
2018-05-15 |
2021-03-31 |
Flagship Pioneering Innovations V Inc |
Composiciones de fusosoma y usos de estas.
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
WO2020014209A1
(en)
|
2018-07-09 |
2020-01-16 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
US20210261957A1
(en)
|
2018-07-10 |
2021-08-26 |
Alia Therapeutics S.R.L. |
Vesicles for traceless delivery of guide rna molecules and/or guide rna molecule/rna-guided nuclease complex(es) and a production method thereof
|
|
US12084698B2
(en)
|
2018-07-13 |
2024-09-10 |
Kyoto University |
Virus-like particles and use thereof
|
|
WO2020027982A1
(en)
|
2018-08-02 |
2020-02-06 |
Editas Medicine, Inc. |
Compositions and methods for treating cep290-associated disease
|
|
CN112805379B
(zh)
|
2018-08-03 |
2024-08-20 |
比姆医疗股份有限公司 |
多效应核碱基编辑器和使用其修饰核酸靶序列的方法
|
|
US20230021641A1
(en)
|
2018-08-23 |
2023-01-26 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
|
CN113286880A
(zh)
|
2018-08-28 |
2021-08-20 |
旗舰先锋创新Vi有限责任公司 |
调控基因组的方法和组合物
|
|
US20240173430A1
(en)
|
2018-09-05 |
2024-05-30 |
The Broad Institute, Inc. |
Base editing for treating hutchinson-gilford progeria syndrome
|
|
AU2019336245B2
(en)
|
2018-09-07 |
2026-02-26 |
Beam Therapeutics Inc. |
Compositions and methods for delivering a nucleobase editing system
|
|
EP3850088A4
(en)
|
2018-09-07 |
2023-07-19 |
Beam Therapeutics, Inc. |
Compositions and methods for improving base editing
|
|
EP3852813A4
(en)
|
2018-09-18 |
2022-06-22 |
VNV Newco Inc. |
ARC-BASED CAPSIDS AND THEIR USES
|
|
US20210403907A1
(en)
|
2018-09-18 |
2021-12-30 |
Vnv Newco Inc. |
Arc-based capsids and uses thereof
|
|
US20220025397A1
(en)
|
2018-09-28 |
2022-01-27 |
The Regents Of The University Of California |
Ligand-directed targeting vectors
|
|
TW202035685A
(zh)
|
2018-10-17 |
2020-10-01 |
美商聖堤生物科技股份有限公司 |
組合癌症免疫療法
|
|
MX2021004470A
(es)
|
2018-10-19 |
2021-09-14 |
Ohio State Innovation Foundation |
Vesículas extracelulares para terapias dirigidas contra células supresoras de origen mieloide.
|
|
CN113302291B
(zh)
|
2018-10-22 |
2025-04-18 |
罗切斯特大学 |
使用逆转录病毒整合酶-Cas9融合蛋白通过定向非同源DNA插入进行的基因组编辑
|
|
US20220380740A1
(en)
|
2018-10-24 |
2022-12-01 |
The Broad Institute, Inc. |
Constructs for improved hdr-dependent genomic editing
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
WO2020102503A2
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for t cell delivery
|
|
CA3120082A1
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for cns delivery
|
|
WO2020102485A1
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
|
AU2019378036B2
(en)
|
2018-11-14 |
2026-05-07 |
Flagship Pioneering Innovations V, Inc |
Compositions and methods for compartment-specific cargo delivery
|
|
WO2020102659A1
(en)
|
2018-11-15 |
2020-05-22 |
The Broad Institute, Inc. |
G-to-t base editors and uses thereof
|
|
EP3880717A4
(en)
|
2018-11-16 |
2022-11-23 |
The Regents of The University of California |
Compositions and methods for delivering crispr/cas effector polypeptides
|
|
WO2020139978A1
(en)
|
2018-12-27 |
2020-07-02 |
Verimmune Llc |
Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
|
|
WO2020160418A1
(en)
|
2019-01-31 |
2020-08-06 |
Board Of Regents Of The University Of Nebraska |
Virus-like particles and methods of use thereof
|
|
WO2020160481A1
(en)
|
2019-02-01 |
2020-08-06 |
The General Hospital Corporation |
Targetable 3'-overhang nuclease fusion proteins
|
|
EP3921432A1
(en)
|
2019-02-04 |
2021-12-15 |
Codiak BioSciences, Inc. |
Membrane protein scaffolds for exosome engineering
|
|
US20220177877A1
(en)
|
2019-03-04 |
2022-06-09 |
President And Fellows Of Harvard College |
Highly multiplexed base editing
|
|
EP4219700A1
(en)
|
2019-03-07 |
2023-08-02 |
The Regents of the University of California |
Crispr-cas effector polypeptides and methods of use thereof
|
|
US20200347100A1
(en)
|
2019-03-15 |
2020-11-05 |
The Broad Institute, Inc. |
Non-naturally occurring capsids for delivery of nucleic acids and/or proteins
|
|
EP3942043A2
(en)
|
2019-03-19 |
2022-01-26 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
EP3715453A1
(en)
|
2019-03-26 |
2020-09-30 |
Johann Wolfgang Goethe-Universität Frankfurt |
Methods and products for a safe and efficient transduction of gene editing components
|
|
WO2020205681A1
(en)
|
2019-03-29 |
2020-10-08 |
Massachusetts Institute Of Technology |
Constructs for continuous monitoring of live cells
|
|
US20220204975A1
(en)
|
2019-04-12 |
2022-06-30 |
President And Fellows Of Harvard College |
System for genome editing
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
US20220184225A1
(en)
|
2019-04-23 |
2022-06-16 |
Case Western Reserve University |
Fusogenic particles and related methods for delivering therapeutic agents to cells
|
|
WO2020225287A1
(en)
|
2019-05-06 |
2020-11-12 |
Veterinärmedizinische Universität Wien |
Lentiviral nanoparticles
|
|
CN114258398A
(zh)
|
2019-06-13 |
2022-03-29 |
总医院公司 |
工程化的人内源性病毒样颗粒及使用其递送至细胞的方法
|
|
GB201910651D0
(en)
|
2019-07-25 |
2019-09-11 |
Autolus Ltd |
Virus-like particle
|
|
US11401530B2
(en)
|
2019-08-19 |
2022-08-02 |
The Catholic University Of America |
Bacteriophage-based artificial viruses for human genome remodeling
|
|
CN119913134A
(zh)
|
2019-08-29 |
2025-05-02 |
比姆医疗股份有限公司 |
用于编辑突变以允许转录或表达的组合物和方法
|
|
AU2020341454A1
(en)
|
2019-09-03 |
2022-03-10 |
Sana Biotechnology, Inc. |
CD24-associated particles and related methods and uses thereof
|
|
AU2020345830A1
(en)
|
2019-09-09 |
2022-03-24 |
Beam Therapeutics Inc. |
Novel CRISPR enzymes, methods, systems and uses thereof
|
|
AU2020344553A1
(en)
|
2019-09-09 |
2022-04-07 |
Scribe Therapeutics Inc. |
Compositions and methods for use in immunotherapy
|
|
EP4031561A1
(en)
|
2019-09-20 |
2022-07-27 |
The Broad Institute, Inc. |
Compositions and methods for delivering cargo to a target cell
|
|
US20230025039A1
(en)
|
2019-09-20 |
2023-01-26 |
The Broad Institute, Inc. |
Novel type vi crispr enzymes and systems
|
|
JP2022550130A
(ja)
|
2019-09-26 |
2022-11-30 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
最小アレスチンドメイン含有蛋白質１（ａｒｒｄｃ１）コンストラクト
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
GB201915855D0
(en)
|
2019-10-31 |
2019-12-18 |
Univ Oxford Innovation Ltd |
An extracellular vesicle
|
|
WO2021091974A1
(en)
|
2019-11-08 |
2021-05-14 |
The Regents Of The University Of California |
Compositions and methods for temporal control of cell modulation
|
|
EP4061941A4
(en)
|
2019-11-19 |
2023-12-06 |
The Broad Institute, Inc. |
RETROTRANSPOSONS AND THEIR USE
|
|
US20230086199A1
(en)
|
2019-11-26 |
2023-03-23 |
The Broad Institute, Inc. |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
|
CN121759549A
(zh)
|
2019-12-03 |
2026-03-31 |
比姆医疗股份有限公司 |
合成向导rna、其组合物、方法和用途
|
|
EP4069716A1
(en)
|
2019-12-06 |
2022-10-12 |
Scribe Therapeutics Inc. |
Particle delivery systems
|
|
CA3171066A1
(en)
|
2020-03-11 |
2021-09-16 |
Saar GILL |
Methods and composition for gene delivery using an engineered viral particle
|
|
WO2021184022A1
(en)
|
2020-03-13 |
2021-09-16 |
Codiak Biosciences, Inc. |
Targeted delivery of extracellular vesicles
|
|
CA3170493A1
(en)
|
2020-03-13 |
2021-09-16 |
Stephen John GOULD |
Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mechanisms
|
|
US20230174598A1
(en)
|
2020-03-18 |
2023-06-08 |
University Of Florida Research Foundation, Incorporated |
Modified arrestin-1 to enhance photoreceptor survival in retinal disease
|
|
AU2021236683A1
(en)
|
2020-03-19 |
2022-11-17 |
Intellia Therapeutics, Inc. |
Methods and compositions for directed genome editing
|
|
US20230365989A1
(en)
|
2020-03-20 |
2023-11-16 |
The Broad Institute, Inc. |
Compositions and methods for enhanced lentiviral production
|
|
EP4127144A1
(en)
|
2020-03-31 |
2023-02-08 |
Sana Biotechnology, Inc. |
Targeted lipid particles and compositions and uses thereof
|
|
AU2021264512A1
(en)
|
2020-04-27 |
2022-11-17 |
Aruna Bio, Inc. |
Binding agents and uses thereof for central nervous system delivery
|
|
WO2021222318A1
(en)
|
2020-04-28 |
2021-11-04 |
The Broad Institute, Inc. |
Targeted base editing of the ush2a gene
|
|
JP2023524733A
(ja)
|
2020-05-04 |
2023-06-13 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
遺伝子発現を活性化及びサイレンシングするためのエフェクタードメインの作出、同定及び性質決定のための組成物、システム及び方法
|
|
BR112022022603A2
(pt)
|
2020-05-08 |
2023-01-17 |
Broad Inst Inc |
Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
|
|
US11129892B1
(en)
|
2020-05-18 |
2021-09-28 |
Vnv Newco Inc. |
Vaccine compositions comprising endogenous Gag polypeptides
|
|
CA3181861A1
(en)
|
2020-06-12 |
2021-12-16 |
Quan Lu |
Arrdc1-mediated microvesicle-based delivery to the nervous system
|
|
US20220002718A1
(en)
|
2020-06-23 |
2022-01-06 |
The General Hospital Corporation |
Tunneling nanotube cells and methods of use thereof for delivery of biomolecules
|
|
MX2023000358A
(es)
|
2020-07-06 |
2023-03-14 |
Flagship Pioneering Innovations V Inc |
Metodos y composiciones para producir fusosomas virales.
|
|
CN116670154A
(zh)
|
2020-07-24 |
2023-08-29 |
总医院公司 |
增强的病毒样颗粒及使用其递送至细胞的方法
|
|
EP4371564B1
(en)
|
2020-07-29 |
2026-03-18 |
The Catholic University Of America |
Design of bacteriophage-based artificial viruses for human genome remodeling
|
|
JP2023543803A
(ja)
|
2020-09-24 |
2023-10-18 |
ザ ブロード インスティテュート，インコーポレーテッド |
プライム編集ガイドｒｎａ、その組成物、及びその使用方法
|
|
CA3094859A1
(en)
|
2020-10-01 |
2022-04-01 |
Entos Pharmaceuticals Inc. |
Proteolipid vesicles formulated with fusion associated small transmembrane proteins
|
|
WO2022081987A1
(en)
|
2020-10-16 |
2022-04-21 |
President And Fellows Of Harvard College |
Ww-domain-activated extracellular vesicles
|
|
JP2023545827A
(ja)
|
2020-10-16 |
2023-10-31 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
コロナウイルスを標的にするｗｗドメイン活性化細胞外ベシクル
|
|
JP2023546156A
(ja)
|
2020-10-16 |
2023-11-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Ｈｉｖを標的にするｗｗドメイン活性化細胞外ベシクル
|
|
AU2021364781B2
(en)
|
2020-10-21 |
2025-10-09 |
Massachusetts Institute Of Technology |
Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
|
|
CA3197147A1
(en)
|
2020-11-04 |
2022-05-12 |
Senti Biosciences, Inc. |
Protein payload release
|
|
AU2021381397A1
(en)
|
2020-11-19 |
2023-06-15 |
Wake Forest University Health Sciences |
Vectors, systems and methods for eukaryotic gene editing
|
|
EP4256045A4
(en)
|
2020-12-02 |
2025-01-08 |
The Regents of the University of California |
Crispr-cas effector polypeptides and methods of use thereof
|
|
WO2022133266A1
(en)
|
2020-12-18 |
2022-06-23 |
The Broad Institute, Inc. |
Evolution of botulinum neurotoxin proteases
|
|
CA3204161A1
(en)
|
2021-01-11 |
2022-07-14 |
Jagesh Vijaykumar SHAH |
Use of cd8-targeted viral vectors
|
|
AU2022214170A1
(en)
|
2021-01-27 |
2023-08-24 |
Aera Therapeutics, Inc. |
Pnma2-based capsids and uses thereof
|
|
WO2022165262A1
(en)
|
2021-01-28 |
2022-08-04 |
The Broad Institute, Inc. |
Compositions and methods for delivering cargo to a target cell
|
|
EP4291202A4
(en)
|
2021-02-09 |
2025-01-08 |
The Broad Institute Inc. |
NUCLEASE-GUIDED NON-LTR RETROTRANSPOSONS AND USES THEREOF
|
|
US20220287968A1
(en)
|
2021-03-09 |
2022-09-15 |
Florida State University Research Foundation, Inc. |
Lipid vesicle-mediated delivery to cells
|
|
AU2022253020A1
(en)
|
2021-04-08 |
2023-10-26 |
Sana Biotechnology, Inc. |
Cd8-specific antibody constructs and compositions thereof
|
|
CA3217115A1
(en)
|
2021-04-30 |
2022-11-03 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting lipid nanoparticle therapeutics to stem cells
|
|
US12565647B2
(en)
|
2021-05-28 |
2026-03-03 |
The Regents Of The University Of California |
Compositions and methods for targeted delivery of CRISPR-Cas effector polypeptides and transgenes
|
|
WO2022251712A1
(en)
|
2021-05-28 |
2022-12-01 |
Sana Biotechnology, Inc. |
Lipid particles containing a truncated baboon endogenous retrovirus (baev) envelope glycoprotein and related methods and uses
|
|
EP4351660A2
(en)
|
2021-06-09 |
2024-04-17 |
Scribe Therapeutics Inc. |
Particle delivery systems
|
|
US20240207196A1
(en)
|
2021-06-09 |
2024-06-27 |
Scribe Therapeutics Inc. |
Compositions of glycoprotein particles
|
|
US20240344083A1
(en)
|
2021-08-04 |
2024-10-17 |
Sana Biotechnology, Inc. |
Use of cd4-targeted viral vectors
|
|
WO2023023055A1
(en)
|
2021-08-16 |
2023-02-23 |
Renagade Therapeutics Management Inc. |
Compositions and methods for optimizing tropism of delivery systems for rna
|
|
WO2023076898A1
(en)
|
2021-10-25 |
2023-05-04 |
The Broad Institute, Inc. |
Methods and compositions for editing a genome with prime editing and a recombinase
|
|
US20250230511A1
(en)
|
2021-10-29 |
2025-07-17 |
Sana Biotechnology, Inc. |
Methods and reagents for amplifying viral vector nucleic acid products
|
|
WO2023077148A1
(en)
|
2021-11-01 |
2023-05-04 |
Tome Biosciences, Inc. |
Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo
|
|
US20250064979A1
(en)
|
2021-12-03 |
2025-02-27 |
The Broad Institute, Inc. |
Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
|
|
CA3239381A1
(en)
|
2021-12-03 |
2023-06-08 |
David R. Liu |
Compositions and methods for efficient in vivo delivery
|
|
WO2023102537A2
(en)
|
2021-12-03 |
2023-06-08 |
The Broad Institute, Inc. |
Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods of making and using same
|
|
CA3240461A1
(en)
|
2021-12-09 |
2023-06-15 |
Robert MILLMAN |
Arrdc1-mediated microvesicles (armms) degrading system and uses thereof
|
|
WO2023114949A1
(en)
|
2021-12-16 |
2023-06-22 |
Sana Biotechnology, Inc. |
Methods and systems of particle production
|
|
WO2023115041A1
(en)
|
2021-12-17 |
2023-06-22 |
Sana Biotechnology, Inc. |
Modified paramyxoviridae attachment glycoproteins
|
|
US20250059239A1
(en)
|
2021-12-17 |
2025-02-20 |
Sana Biotechnology, Inc. |
Modified paramyxoviridae fusion glycoproteins
|
|
EP4452335A1
(en)
|
2021-12-22 |
2024-10-30 |
Tome Biosciences, Inc. |
Co-delivery of a gene editor construct and a donor template
|
|
GB202118946D0
(en)
|
2021-12-23 |
2022-02-09 |
Evox Therapeutics Ltd |
Engineered extracellular vesicles with improved cargo delivery
|
|
WO2023129993A2
(en)
|
2021-12-29 |
2023-07-06 |
Intima Bioscience, Inc. |
Antigen delivery platform and methods of use
|
|
EP4460574A4
(en)
|
2022-01-04 |
2026-01-14 |
Broad Inst Inc |
COMPOSITIONS AND METHODS OF CARGO ADMINISTRATION TO A TARGET CELL
|
|
WO2023133425A1
(en)
|
2022-01-04 |
2023-07-13 |
The Broad Institute, Inc. |
Compositions and methods for delivering cargo to a target cell
|
|
WO2023173028A2
(en)
|
2022-03-09 |
2023-09-14 |
The Regents Of The University Of Colorado A Body Corporate |
Tissue and cell-type specific delivery of therapeutic molecules incorporating viral and human fusiogenic proteins
|
|
EP4493157A2
(en)
|
2022-03-11 |
2025-01-22 |
President and Fellows of Harvard College |
Targeted delivery of armms
|
|
EP4511486A1
(en)
|
2022-04-20 |
2025-02-26 |
Massachusetts Institute Of Technology |
Site specific genetic engineering utilizing trans-template rnas
|
|
WO2023205710A1
(en)
|
2022-04-20 |
2023-10-26 |
Massachusetts Institute Of Technology |
Programmable gene editing using guide rna pair
|
|
WO2023205744A1
(en)
|
2022-04-20 |
2023-10-26 |
Tome Biosciences, Inc. |
Programmable gene insertion compositions
|
|
WO2023215831A1
(en)
|
2022-05-04 |
2023-11-09 |
Tome Biosciences, Inc. |
Guide rna compositions for programmable gene insertion
|
|
CN120303407A
(zh)
|
2022-05-17 |
2025-07-11 |
恩维洛普治疗有限责任公司 |
用于有效体内递送的组合物和方法
|
|
WO2023225670A2
(en)
|
2022-05-20 |
2023-11-23 |
Tome Biosciences, Inc. |
Ex vivo programmable gene insertion
|
|
EP4532525A1
(en)
|
2022-05-25 |
2025-04-09 |
Massachusetts Institute Of Technology |
Systems, methods, and compositions for rna-guided rna-targeting crispr effectors with cas7-11 variants
|
|
WO2023230601A1
(en)
|
2022-05-27 |
2023-11-30 |
Beam Therapeutics Inc. |
Identification of nanoparticles for preferential tissue or cell targeting
|
|
WO2023240124A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Pseudotyped viral particles for targeting tcr-expressing cells
|
|
WO2023240027A1
(en)
|
2022-06-07 |
2023-12-14 |
Scribe Therapeutics Inc. |
Particle delivery systems
|
|
WO2023245134A2
(en)
|
2022-06-15 |
2023-12-21 |
Vesigen, Inc. |
Arrdc1-mediated micro vesicle-based delivery of therapeutic agents to cells of the peripheral nervous system
|
|
WO2024006988A2
(en)
|
2022-06-30 |
2024-01-04 |
The Broad Institute, Inc. |
Engineered delivery vesicles and uses thereof
|
|
EP4558128A1
(en)
|
2022-07-21 |
2025-05-28 |
Institut National de la Santé et de la Recherche Médicale |
Extracellular vesicles functionalized with an erv syncitin and uses thereof for cargo delivery
|
|
GB202210861D0
(en)
|
2022-07-25 |
2022-09-07 |
Univ Oxford Innovation Ltd |
Loaded extracellular vesicle
|
|
WO2024026295A1
(en)
|
2022-07-27 |
2024-02-01 |
Aera Therapeutics, Inc. |
Endogenous gag-based and pnma family capsids and uses thereof
|
|
US20260055146A1
(en)
|
2022-08-24 |
2026-02-26 |
Sana Biotechnology, Inc. |
Delivery of heterologous proteins
|
|
WO2024050007A1
(en)
|
2022-08-31 |
2024-03-07 |
The Broad Institute, Inc. |
Gtp cyclohydrolase-cleaving proteases
|
|
WO2024081820A1
(en)
|
2022-10-13 |
2024-04-18 |
Sana Biotechnology, Inc. |
Viral particles targeting hematopoietic stem cells
|
|
WO2024107983A1
(en)
|
2022-11-16 |
2024-05-23 |
The General Hospital Corporation |
Virus-like particles with programmable tropism and methods of use thereof for delivery to cells
|
|
US20240189247A1
(en)
|
2022-11-16 |
2024-06-13 |
The General Hospital Corporation |
Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules
|
|
WO2024107959A1
(en)
|
2022-11-16 |
2024-05-23 |
The General Hospital Corporation |
Minimal virus-like particles and methods of use thereof for delivery of biomolecules
|
|
WO2024138033A2
(en)
|
2022-12-21 |
2024-06-27 |
Nvelop Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acid editors
|